Search
Language
search
China National Pharmaceutical Group Co Ltd (Sinopharm) is a centrally-administered State-owned enterprise under the direct management of the State-owned Assets Supervision and Administration Commission of the State Council (SASAC).Sinopharm is a globally leading company in the healthcare sector in terms of scale, performance and comprehensive strength. With a primary focus on life & health, the company owns a complete industrial chain covering R&D, manufacturing, logistics and distribution, retail chains, healthcare, engineering technology, exhibitions and events, international business and financial services.
The company will build a globally competitive holistic healthcare group that will make new and greater contributions to China’s new journey toward growing into a modern socialist country in all respects.
In 2021, the total assets of Sinopharm amounted to 564 billion RMB, and the total profit exceeded 100 billion RMB. Sinopharm ranked first among central enterprises in PATMI, return on equity, and hedging and proliferating ratios of state-owned assets, with its scale and benefit, and comprehensive strength leading the industry. Sinopharm was awarded by SASAC as “A-level business performance of the person in charge of central enterprises” in 2021 and during the term of office from 2019 to 2021, and "Excellent enterprise in the performance evaluations of 2019-2021". For nine consecutive years and three consecutive terms, Sinopharm has been rated as an A-level enterprise in the business performance evaluations of persons-in-charge at central enterprises, and from 2019 to 2021, Sinopharm has been graded A-level in reference to the work of party building among central enterprises.
Sinopharm has firmly established and practiced the new development concept, actively undertaken a number of central reform pilot tasks, achieving positive results. Sinopharm is among the first batch of the board of directors pilot project, a test unit for exercising the authority of the board of directors, and the first one which has completed the equity diversification reform at the group level among central enterprises. By focusing on the construction and improvement of the modern enterprise system, actively exploring new models of corporate governance, Sinopharm has further strengthened the dominant position in the market. At the same time, as a pilot central enterprise to develop the mixed-ownership economy, Sinopharm has proactively explored and promoted the development of enterprise system, strategic management and control, operation mechanism and talent incentive, stimulating various vitality and nurturing market-oriented operating mechanism to constantly enhance the vitality and influence of state-owned asset.
The company will build a globally competitive holistic healthcare group that will make new and greater contributions to China’s new journey toward growing into a modern socialist country in all respects.
In 1950, China National Pharmaceutical (Group) Corporation (the predecessor of Sinopharm) was established with the approval of the Government Administration Council of the Central People's Government to shoulder the historical mission of securing public health safety as well as the life and health of Chinese people." To unify the leadership of purchase, sale and production of national medicine and promote the development of Chinese pharmaceutical industry" is not only the common wish of the central government and the people but also the original aspiration of Sinopharm.
Directly led by SASAC, Sinopharm is the only central State-owned enterprise focusing on life and health.
Adhering to the principle of putting people and their lives first, Sinopharm is the only enterprise worldwide that independently develops 4 diagnostic reagents, 4 specific treatments and technologies, and 4 COVID-19 vaccines on the three fronts of diagnosable, curable, and preventable. The Sinopharm COVID-19 vaccine has registered in 119 countries, regions, and international organizations, and the vaccination population covers 196 countries.
Sinopharm is dedicated to serving healthy China and building a world-class comprehensive pharmaceutical and healthcare industry group.
Sinopharm Stores
Sinopharm Stores
